FDA Approves Avsola (infliximab-axxq), a Biosimilar to Remicade
THOUSAND OAKS, Calif., Dec. 6, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Avsola (infliximab-axxq) for all approved indicati
Latest News
NDA News
2436
•
Read All
News
- CLINIEXPERT -
Int'l Clinical Service Expert
We are the leader
Because of our professionism
